Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.
Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.
Aveanna Healthcare Holdings, Inc. (AVAH) SVP, Chief Accounting Officer Deborah Stewart acquired a 75,000-share grant of stock-settled restricted stock units on October 1, 2026, subject to three-year cliff vesting. Her reported direct holdings following the transaction were 377,844 shares, including 1,037 shares acquired under the company's Employee Stock Purchase Plan in June 2026.
Aveanna Healthcare Holdings, Inc. (AVAH) said Steven E. Rodgers, a Class II director, notified the company on October 1, 2026, of his decision to resign, effective immediately. Before resigning, Rodgers was an independent director and served on both the Audit Committee and the Compensation Committee. The company said his decision was not due to any disagreement concerning its operations, policies, or practices.
Aveanna Healthcare Holdings, Inc. (AVAH) director Erica G. Schwartz has filed a Rule 144 notice covering the potential sale of up to 46,071 shares of common stock on NASDAQ, with an aggregate market value of $644,994.00, based on an outstanding share count of 218,219,696 shares as of September 9, 2026.
The shares to be sold come from restricted stock granted by the issuer on February 14, 2026, July 22, 2026, and February 14, 2025. Schwartz also reports that during the prior three months she sold 230,343 shares of AVAH common stock for total proceeds of $3,224,802.00.
Aveanna Healthcare Holdings, Inc. (AVAH) received a Form 144 notice indicating that director Erica G. Schwartz intends to sell up to 230,343 shares of Aveanna common stock under Rule 144. The proposed sale, to be executed through Morgan Stanley Smith Barney LLC, has an approximate aggregate market value of $3,224,802.00 and references Aveanna common shares outstanding of 218,219,696. The shares derive from multiple restricted stock awards granted between January 2023 and February 2025.
Aveanna Healthcare Holdings, Inc. (AVAH) had a major shareholder, J.H. Whitney Equity Partners VII, LLC, report significant sales of common stock through affiliated entities. On August 20–21, 2026, entities associated with this reporting person sold a total of 14,746,077 shares of common stock at $11.50 per share in an underwritten secondary offering, including sales by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC. After these transactions, J.H. Whitney VII, L.P. and PSA Iliad Holdings LLC reported 0 shares held, the reporting person reported no direct holdings, and the filing states that the reporting person and certain affiliates disclaim beneficial ownership except to the extent of their pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) reported that entities associated with reporting person Robert M. Williams, Jr., a ten percent owner, executed a series of indirect sales of 16,750,002 shares of common stock at $11.50 per share on August 20–21, 2026. According to the footnotes, J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings, LLC, JHW Iliad Holdings II, LLC and PSA Iliad Holdings LLC sold these shares in an underwritten secondary offering, including sales pursuant to an option to purchase additional shares. Williams is described as associated with the managing or controlling entities of these stockholder entities and disclaims beneficial ownership of the securities except to the extent of his pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) reports that entities associated with reporting person Paul R. Vigano sold an aggregate of 16,750,002 shares of common stock in underwritten secondary offerings at $11.50 per share on August 20–21, 2026. The sales were made indirectly through several investment and holding entities, and Vigano disclaims beneficial ownership except to the extent of his pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) director Rodney D. Windley reported selling 180,000 shares of common stock on August 20, 2026 at $11.50 per share. The sale was part of a 15,000,000‑share secondary offering of Aveanna common stock that closed on August 24, 2026, and left him holding 2,078,017 shares directly.
Aveanna Healthcare Holdings, Inc. (AVAH) reported that Chief Executive Officer Jeff Shaner sold 90,000 shares of common stock on August 20, 2026 at $11.50 per share, as part of an underwritten secondary offering of 15,000,000 shares. Following this sale, he directly holds 2,561,972 shares, which include 1,080 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.
Aveanna Healthcare Holdings, Inc. (AVAH) reports that Chief Administrative Officer Edwin C. Reisz sold 50,000 shares of common stock on August 20, 2026 at $11.50 per share. The shares were sold as part of an underwritten secondary offering of 15,000,000 shares of Aveanna common stock that closed on August 24, 2026. After this sale, Reisz beneficially holds 1,397,897 shares, which includes 840 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.